THOMAS KING: Open Payments
NPI 1497005268 · JAMESTOWN, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$620 in 34 payments from 9 companies in 2025. Trend: 2023 $528 · 2024 $198 · 2025 $620
Food & beverage: $620
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 12 | $192 |
| Indivior Inc. | 8 | $144 |
| ABBVIE INC. | 5 | $93 |
| Braeburn Inc. | 4 | $85 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $27 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $26 |
| Vanda Pharmaceuticals Inc. | 1 | $19 |
| Janssen Pharmaceuticals, Inc | 1 | $19 |
| E.R. Squibb & Sons, L.L.C. | 1 | $14 |
Products named: Korlym, SUBLOCADE, BRIXADI, MAVYRET, JOURNAVX, CAPLYTA, QULIPTA, HETLIOZ.
Industry payments across CA — which companies pay providers there.
